Background illustration for clinical trials search

Paid Clinical Trials Beaumont

Discover 76 paid clinical trials in Beaumont, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 76

Rocklatan vs Latanoprost Post-DSLT

for

Glaucoma

Location: Beaumont TX

Sponsor: Eye Centers of Southeast Texas

Sex: All

Age: 18+

Code: NCT07465913

Recruiting

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens

for

Myopia, Juvenile Myopia, Myopia Progression

Location: Beaumont TX, Bellaire TX, Pittsburg KS, Raytown MO,

Sponsor: SightGlass Vision, Inc.

Sex: All

Age: 6 - 8

Code: NCT06034327

Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

for

Systemic Lupus Erythematosus

Location: Lake Charles LA, Houston TX, Bellaire TX,

Sponsor: UCB Biopharma SRL

Sex: All

Age: 16+

Code: NCT06617325

Phase3, Recruiting

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

for

Pulmonary Disease, Chronic Obstructive

Location: Lake Charles LA, Houston TX, Stafford TX, Katy TX,

Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT07177339

Phase3, Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for

Plaque Psoriasis

Location: Lake Charles LA, Webster TX, Houston TX, Cypress TX,

Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase3, Recruiting

Utility of PharmacoGenomics for Reducing Adverse Drug Effects

for

Genetics of Drug Metabolism

Location: Lake Charles LA, League City TX, Waco TX, Austin TX,

Sponsor: Companion Dx Reference Lab, LLC

Sex: All

Age: 18+

Code: NCT02081872

Recruiting

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

for

Systemic Lupus Erythematosus

Location: Lake Charles LA, League City TX, Red Oak TX, Memphis TN,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06133972

Phase3, Recruiting

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

for

Arthritis, Psoriatic

Location: Lake Charles LA, Baytown TX, Austin TX, Colleyville TX,

Sponsor: MoonLake Immunotherapeutics AG

Sex: All

Age: 18+

Code: NCT06641089

Phase3, Recruiting

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

for

Rheumatoid Arthritis

Location: Lake Charles LA, Baytown TX, Houston TX, Tomball TX,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07276581

Phase2, Recruiting

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

for

Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus

Location: Lake Charles LA, Humble TX, Frisco TX, Tampa FL,

Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07355218

Phase3, Recruiting

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

for

Psoriatic Arthritis

Location: Lake Charles LA, Houston TX, Bellaire TX, Baytown TX,

Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06671483

Phase3, Recruiting

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

for

AL Amyloidosis

Location: Baytown TX, Nassau Bay TX, The Woodlands TX, Houston TX,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06022939

Phase3, Recruiting

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

for

Locally Advanced Urothelial Carcinoma,

Location: Baytown TX, Nassau Bay TX, The Woodlands TX, Houston TX,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06524544

Phase3, Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for

Anatomic Stage I Breast Cancer AJCC v8,

Location: Baytown TX, Nassau Bay TX, League City TX, Houston TX,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase3, Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

for

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma,

Location: Baytown TX, Nassau Bay TX, League City TX,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06958328

Phase3, Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for

Prostate Cancer (Adenocarcinoma)

Location: Baytown TX, Nassau Bay TX, The Woodlands TX, Houston TX,

Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase3, Recruiting

Modifying the Inpatient Environment to Reduce Delirium in Older Adults

for

Delirium, Sleep Hygiene

Location: Baytown TX, Houston TX, Sugarland TX

Sponsor: Farhaan S. Vahidy

Sex: All

Age: 70+

Code: NCT06736951

Recruiting

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

for

Smoldering Plasma Cell Myeloma

Location: Baytown TX, Nassau Bay TX, The Woodlands TX, Houston TX,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT03937635

Phase3, Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for

Advanced Lung Non-Squamous Non-Small Cell Carcinoma,

Location: Baytown TX, Nassau Bay TX, The Woodlands TX, Houston TX,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase3, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for

Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),

Location: Baytown TX, Nassau Bay TX, The Woodlands TX, Houston TX,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

Paid Clinical Trials Beaumont

Filter results

Rocklatan vs Latanoprost Post-DSLT

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Interested in new trials?

Utility of PharmacoGenomics for Reducing Adverse Drug Effects

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Modifying the Inpatient Environment to Reduce Delirium in Older Adults

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer